Neogen NEOG
NASDAQ NEOG
$11.51 -0.09 (-0.78%)
As of: Nov 12, 2026 · 9:30 AM EST

Neogen (NEOG) Gains (Losses) on Sale of Assets & Investments (2025 - 2026)

Updated

Neogen (NEOG) posted Non Operating Investment Income of -$400,000 for fiscal Q1 2027 (quarter ended Aug 31, 2026), compared with $76.4 million a year earlier.

Analysis

Neogen (NEOG) Gains (Losses) on Sale of Assets & Investments (2025 - 2026) Analysis & Trends

For FY2026 (ended May 31, 2026), Neogen's Non Operating Investment Income came in at $76.4 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn -
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn -
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn -
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn -
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn -
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn -
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn -
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 13.00 Mn
10 Neogen 2.55 Bn 1.88 Bn 105.50 Mn -400,000.00
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 -400,000.00
Aug 31, 2025 76.40 Mn
API Access

Neogen Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NEOG&period=max&api_key=YOUR_API_KEY